Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients (vol 50, 1700050, 2017 )

被引：2
|
作者：
Delaunay, Myriam
Cadranel, Jacques
Lusque, Amelie
Meyer, Nicolas
Gounant, Valerie
Moro-Sibilot, Denis
Michot, Jean-Marie
Raimbourg, Judith
Girard, Nicolas
Guisier, Florian
Planchard, David
Metivier, Anne-Cecile
Tomasini, Pascale
Dansin, Eric
Perol, Maurice
Campana, Marion
Gautschi, Oliver
Fruh, Martin
Fumet, Jean-David
Audigier-Valette, Clarisse
Couraud, Sebastien
Dalle, Stephane
Leccia, Marie-Therese
Jaffro, Marion
Collot, Samia
Prevot, Gregoire
Milia, Julie
Mazieres, Julien
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷 / 05期
关键词：
D O I：
10.1183/13993003.50050-2017
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors
    Roch, Benoit
    Coffy, Amandine
    Jean-Baptiste, Sandy
    Palaysi, Estelle
    Daures, Jean-Pierre
    Pujol, Jean-Louis
    Bommart, Sebastien
    LUNG CANCER, 2020, 143 : 19 - 26
  • [32] Efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer patients with different metastases
    Qiao, Meng
    Zhou, Fei
    Hou, Likun
    Li, Xuefei
    Zhao, Chao
    Jiang, Tao
    Gao, Guanghui
    Su, Chunxia
    Wu, Chunyan
    Ren, Shengxiang
    Zhou, Caicun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (01)
  • [33] Immune-Checkpoint Inhibitors: Biomarkers to Predict Response to Immunotherapy in Non-small Cell Lung Cancer Patients
    Tostes, Senhorita Katiane
    Sorroche, Bruna Pereira
    Rodrigues, Nathalia de Carvalho
    Dias, Tauana Christina
    Lima, Joyce Alessandra
    Ferreira da Silva, Flavio Augusto
    Martins de Marchi, Pedro Rafael
    Pinheiro, Celine Marques
    Leal, Leticia Ferro
    Rebolho Batista Arantes, Lidia Maria
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S26 - S26
  • [34] Impact of dose modification of immune-checkpoint inhibitors in lung cancer patients during the COVID-19 pandemic
    Veron, M.
    Pierret, T.
    Perol, M.
    Benet, J.
    Denis, N.
    Moro-Sibilot, D.
    Swalduz, A.
    Toffart, A. C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [35] Cardiotoxicity in Patients With Lung Cancer Receiving Thoracic Radiotherapy and Immune-Checkpoint Therapy
    Son, C.
    Moey, M.
    Naqash, A.
    Walker, P.
    Peach, M. S.
    Ju, A. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E235 - E236
  • [36] Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors
    Hu, Xiao
    Rodday, Angie Mae
    Gurinovich, Anastasia
    Pan, Stacey
    Salei, Yana V.
    Lin, Jeffrey H.
    Byrne, Margaret M.
    Cao, Yu
    Pai, Lori
    Parsons, Susan K.
    IMMUNOTHERAPY, 2025,
  • [37] Development of Mycobacterium avium Complex Lung Disease in Patients With Lung Cancer on Immune Checkpoint Inhibitors
    Fujita, Kohei
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Nakatani, Koichi
    Mio, Tadashi
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (03):
  • [38] Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer
    Indini, Alice
    Nigro, Olga
    Lengyel, Csongor Gyorgy
    Ghidini, Michele
    Petrillo, Angelica
    Lopez, Salvatore
    Raspagliesi, Francesco
    Trapani, Dario
    Khakoo, Shelize
    Bogani, Giorgio
    CANCERS, 2021, 13 (07)
  • [39] Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day
    Maiorano, Brigida Anna
    De Giorgi, Ugo
    Ciardiello, Davide
    Schinzari, Giovanni
    Cisternino, Antonio
    Tortora, Giampaolo
    Maiello, Evaristo
    BIOMEDICINES, 2022, 10 (02)
  • [40] Immune checkpoint inhibitors in lung cancer
    Koleczko, S.
    Wolf, J.
    INTERNIST, 2020, 61 (07): : 676 - 681
12345